CureVac Update on Trial Dates for Patent Litigation Across Geographies Against Pfizer/BioNTech

 

• New trial date for U.S. patent litigation set for March 3, 2025, following settlement with Acuitas Therapeutics

• First instance decision on validity of EP 3 708 668 B1 (split poly-A tail technology) scheduled for March 25, 2025, by European Patent Office in the context of the German patent litigation

• UK trial on validity of intellectual property rights EP 3 708 668 B1 and EP 4 023 755 B1 (split poly-A tail technology) began July 10; judgement expected later in 2024

https://www.biospace.com/article/releases/curevac-provides-update-on-trial-dates-for-patent-litigation-across-multiple-geographies-against-pfizer-biontech/